Imunon Inc (NASDAQ:IMNN)’s traded shares stood at 2.56 million during the last session, with the company’s beta value hitting 2.12. At the close of trading, the stock’s price was $1.66, to imply an increase of 2.47% or $0.04 in intraday trading. The IMNN share’s 52-week high remains $3.65, putting it -119.88% down since that peak but still an impressive 77.71% since price per share fell to its 52-week low of $0.37.
Analysts have given a consensus recommendation of Buy for Imunon Inc (IMNN), translating to a mean rating of 1.67. Of 1 analyst(s) looking at the stock, 0 analyst(s) give IMNN a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.
Imunon Inc (NASDAQ:IMNN) trade information
After registering a 2.47% upside in the last session, Imunon Inc (IMNN) has traded red over the past five days. The 5-day price performance for the stock is -2.35%, and 103.46% over 30 days. With these gigs, the year-to-date price performance is 74.74%.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 32.54% for the past 5-year period. While 2025 is set for a 34.72% return in earnings, projections for the next 5 years are at 31.24% annually.
IMNN Dividends
Imunon Inc has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is GEODE CAPITAL MANAGEMENT, LLC with 74653.0 shares, or about 0.7941% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $86627.0.
